Direxion Daily Pharmaceutical & Medical Bull 3X ETF Rating $16.85 -2.14 (-11.27%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$17.26 +0.41 (+2.43%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatings Direxion Daily Pharmaceutical & Medical Bull 3X ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.74Holdings in PILL have an aggregate rating of Moderate Buy based on 216 analyst ratings issued in the past year covering 19 companies (10.7% of the portfolio).PILL Aggregate Price Target$16.85High Prediction$16.85Average Prediction$16.85Low Prediction$16.85Holdings in PILL have an aggregate price target of $16.85 and a range of $16.85 to $16.85 covering 19 companies (10.7% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 PILL Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings1.00%AMLXAmylyx Pharmaceuticals$30.60-7.3%Buy$38.86 27.0%103.3342 of 5 stars0.82%MBXMBX Biosciences$57.89-6.6%Moderate Buy$77.00 33.0%132.8195 of 5 stars0.72%OMEROmeros$20.74-1.5%Moderate Buy$34.00 63.9%73.9884 of 5 starsAnalyst Upgrade0.66%DFTXDefinium Therapeutics$37.65-6.6%Buy$64.88 72.3%212.8817 of 5 stars0.58%CORTCorcept Therapeutics$112.94-3.9%Moderate Buy$138.17 22.3%83.8661 of 5 stars0.57%EWTXEdgewise Therapeutics$41.05-7.8%Moderate Buy$51.33 25.1%113.3958 of 5 starsPositive NewsAnalyst ForecastHigh Trading Volume0.54%ELVNEnliven Therapeutics$46.09-4.4%Moderate Buy$75.00 62.7%92.2948 of 5 starsPositive NewsInsider Trade0.53%ETONEton Pharmaceuticals$55.61-2.6%Moderate Buy$67.50 21.4%64.4192 of 5 starsAnalyst Upgrade0.53%NUVBNuvation Bio$5.70-6.6%Moderate Buy$13.00 128.3%132.9873 of 5 stars0.51%TARSTarsus Pharmaceuticals$74.29-3.6%Moderate Buy$94.00 26.5%103.3678 of 5 stars0.49%MRKMerck & Co., Inc.$148.07-1.9%Moderate Buy$154.24 4.2%244.1667 of 5 starsTrending News0.48%PRGOPerrigo$13.82-3.5%Hold$19.33 39.9%63.3824 of 5 starsNews Coverage0.48%HRMYHarmony Biosciences$40.48-2.5%Hold$47.11 16.4%114.0089 of 5 stars0.48%NKTRNektar Therapeutics$57.66-5.4%Moderate Buy$138.50 140.2%132.6509 of 5 starsAnalyst Forecast0.47%AMRXAmneal Pharmaceuticals$19.33-0.9%Moderate Buy$21.00 8.6%103.4801 of 5 starsAnalyst Forecast0.46%OCULOcular Therapeutix$10.00-4.8%Moderate Buy$25.75 157.5%133.0134 of 5 starsPositive News0.46%LGNDLigand Pharmaceuticals$298.410.0%Buy$337.00 12.9%93.3747 of 5 starsNews CoverageAnalyst Upgrade0.46%MANEVeradermics$115.73-2.0%Moderate Buy$153.00 32.2%92.6396 of 5 starsPositive News0.45%TRVITrevi Therapeutics$14.46-5.1%Buy$27.08 87.3%133.7887 of 5 starsPositive News This page (NYSEARCA:PILL) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
